CLN8
Protein CLN8
Also known as: C8orf61, CLN8_HUMAN, EPMR, FLJ39417, TLCD6
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UBY8
- Gene
- CLN8
- Ensembl
- ENSG00000182372
- Chromosome
- 8
- Canonical length
- 286 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted membrane proteins
OverviewNCBI Gene
This gene encodes a transmembrane protein belonging to a family of proteins containing TLC domains, which are postulated to function in lipid synthesis, transport, or sensing. The protein localizes to the endoplasmic reticulum (ER), and may recycle between the ER and ER-Golgi intermediate compartment. Mutations in this gene are associated with a disorder characterized by progressive epilepsy with cognitive disabilities (EPMR), which is a subtype of neuronal ceroid lipofuscinoses (NCL). Patients with mutations in this gene have altered levels of sphingolipid and phospholipids in the brain. [provided by RefSeq, Jul 2017]
Canonical amino-acid sequenceUniProt
286 residues, UniProt reviewed canonical sequence.
>Q9UBY8|CLN8
1 MNPASDGGTS ESIFDLDYAS WGIRSTLMVA GFVFYLGVFV VCHQLSSSLN ATYRSLVARE
61 KVFWDLAATR AVFGVQSTAA GLWALLGDPV LHADKARGQQ NWCWFHITTA TGFFCFENVA
121 VHLSNLIFRT FDLFLVIHHL FAFLGFLGCL VNLQAGHYLA MTTLLLEMST PFTCVSWMLL
181 KAGWSESLFW KLNQWLMIHM FHCRMVLTYH MWWVCFWHWD GLVSSLYLPH LTLFLVGLAL
241 LTLIINPYWT HKKTQQLLNP VDWNFAQPEA KSRPEGNGQL LRKKRPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CLN8 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 5
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 19 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 19 nTPM
- skin: 12 nTPM
- midbrain: 11 nTPM
- epididymis: 11 nTPM
- pancreas: 9.3 nTPM
- hippocampal formation: 9.1 nTPM
Single-cell type
- microglia: 4.1 nCPM
- cardiomyocytes: 2 nCPM
- choroid plexus epithelial cells: 1.1 nCPM
- gastric chief cells: 1.1 nCPM
- endometrial secretory cells: 1 nCPM
- kupffer cells: 1 nCPM
Immune cell
- plasmacytoid DC: 77 nTPM
- naive B-cell: 14 nTPM
- intermediate monocyte: 14 nTPM
- non-classical monocyte: 14 nTPM
- classical monocyte: 11 nTPM
- myeloid DC: 11 nTPM
Brain region
- white matter: 49 nTPM
- medulla oblongata: 40 nTPM
- spinal cord: 37 nTPM
- pons: 35 nTPM
- basal ganglia: 33 nTPM
- midbrain: 33 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CLN8.
Disease | AllUniProt
Conditions CLN8 is implicated in, by any mechanism.
- Ceroid lipofuscinosis, neuronal, 8 (CLN8) MIM:600143
- Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant (CLN8NE) MIM:610003
Disease | GeneticClinVar
89 pathogenic / likely-pathogenic of 604 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Neuronal ceroid lipofuscinosis
- Neuronal ceroid lipofuscinosis 8
- Neuronal ceroid lipofuscinosis 8 northern epilepsy variant
- Inborn genetic diseases
- CLN8-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.17
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.77
- DepMap mean gene effect
- 0.22
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adult walking behavior
- associative learning
- ceramide biosynthetic process
- ceramide metabolic process
- cholesterol metabolic process
- glutamate reuptake
- lipid biosynthetic process
- lipid homeostasis
- lipid transport
- lysosome organization
- mitochondrial membrane organization
- musculoskeletal movement
- negative regulation of neuron apoptotic process
- negative regulation of proteolysis
- nervous system development
- neurofilament cytoskeleton organization
- neuromuscular process controlling balance
- neuromuscular process controlling posture
- phospholipid metabolic process
- photoreceptor cell maintenance
- protein catabolic process
- regulation of cell size
- retina development in camera-type eye
- retinal rod cell apoptotic process
- social behavior
- somatic motor neuron differentiation
- visual perception
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CLN8 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CLN8 as an antibody target. Whether an autoantibody or antibody against CLN8 could matter depends on whether native CLN8 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CLN8 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CLN8 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...